Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non–Small-Cell Lung CancerYoshimasa Shiraishi, Isamu Okamoto, Kentaro Tanaka et al.|Clinical Lung Cancer|2020Cited by 15